Vericel (VCEL)
Markets patient-specific cell therapies for knee-cartilage repair and severe burns, plus enzymatic burn debridement.
$40.22
After hours0.00 (0.00%)
At close$40.22(+1.69%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 44 days
EPS estimate
$0.02
Revenue estimate
$78.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Jul '25Nov '25Feb '26May '26Jul '26Nov '26
Reported$0.38−$0.23−$0.01$0.10$0.45−$0.12$0.04Pending
Estimate$0.31−$0.09−$0.04−$0.02$0.45−$0.15−$0.03$0.02
Surprise+22.6%−155.6%+75.0%+600.0%0.0%+20.0%+238.2%—
RevenueReportedEstimate
Feb '25May '25Jul '25Nov '25Feb '26May '26Jul '26Nov '26
Reported$75.4M$52.6M$63.2M$67.5M$92.9M$68.4M$77.5MPending
Estimate$58.1M$64.8M$64.6M$92.7M$91.0M$63.7M$72.7M$78.0M
Surprise+29.7%−18.8%−2.1%−27.2%+2.1%+7.5%+6.5%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.79 | — | — |
| Sep 2028 | $0.24 | — | — |
| Jun 2028 | $0.21 | — | — |
| Mar 2028 | $0.03 | — | — |
| Dec 2027 | $0.62 | — | — |
| Sep 2027 | $0.14 | — | — |
| Jun 2027 | $0.13 | — | — |
| Mar 2027 | −$0.04 | — | — |
| Dec 2026 | $0.57 | — | — |
| Nov 2026 | $0.02 | — | — |
| Jul 2026 | −$0.03 | $0.04 | +238.2% |
| May 2026 | −$0.15 | −$0.12 | +20.0% |
| Feb 2026 | $0.45 | $0.45 | 0.0% |
| Nov 2025 | −$0.02 | $0.10 | +600.0% |
| Jul 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.79 | — | — | $153.6M | — | — | — |
| Sep 2028 | $0.24 | — | — | $105.9M | — | — | — |
| Jun 2028 | $0.21 | — | — | $106.5M | — | — | — |
| Mar 2028 | $0.03 | — | — | $92.8M | — | — | — |
| Dec 2027 | $0.62 | — | — | $131.5M | — | — | — |
| Sep 2027 | $0.14 | — | — | $90.2M | — | — | — |
| Jun 2027 | $0.13 | — | — | $91.5M | — | — | — |
| Mar 2027 | −$0.04 | — | — | $79.4M | — | — | — |
| Dec 2026 | $0.57 | — | — | $112.4M | — | — | — |
| Nov 5, 2026 | $0.02 | — | — | $78.0M | — | — | — |
| Jul 30, 2026 | −$0.03 | $0.04 | +238.2% | $72.7M | $77.5M | +6.5% | +2.1% |
| May 7, 2026 | −$0.15 | −$0.12 | +20.0% | $63.7M | $68.4M | +7.5% | −4.5% |
| Feb 26, 2026 | $0.45 | $0.45 | 0.0% | $91.0M | $92.9M | +2.1% | +1.6% |
| Nov 6, 2025 | −$0.02 | $0.10 | +600.0% | $92.7M | $67.5M | −27.2% | +4.2% |
| Jul 31, 2025 | |||||||
| May 8, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 1, 2024 | |||||||
| May 8, 2024 | |||||||
| Feb 29, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 2, 2023 | |||||||
| May 10, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 3, 2022 | |||||||
| May 4, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 4, 2021 | |||||||
| May 5, 2021 | |||||||
| Feb 24, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 5, 2020 | |||||||
| May 5, 2020 | |||||||
| Feb 25, 2020 | |||||||
| Nov 5, 2019 | |||||||
| Aug 6, 2019 | |||||||
| May 7, 2019 | |||||||
| Feb 26, 2019 | |||||||
| Nov 6, 2018 | |||||||
| Aug 6, 2018 | |||||||
| May 8, 2018 | |||||||
| Mar 5, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 10, 2017 | |||||||
| Mar 10, 2017 | |||||||
| Nov 7, 2016 | |||||||
| Aug 8, 2016 | |||||||
| May 10, 2016 | |||||||
| Mar 14, 2016 | |||||||
| Nov 13, 2015 | |||||||
| Aug 12, 2015 |